GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2008

Sanofi-Aventis Bids Against Anthiarose for Zentiva

  • Yesterday, Anthiarose, a subsidiary of PPF Group, reported a voluntary takeover offer to acquire Zentiva at $60.8 (CZK 950) a share.

    Today, Sanofi-Aventis, the largest Zentiva shareholder, presented a competing bid of $62.7 (CZK 1050) per share.

    Zentiva boasts over 280 products including prescription drugs, OTC products, and food supplements. The firm also manufactures cosmetics and APIs.


Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

New NIH Budget Proposal Leaves Many Confused and Unsettled

Do you think that using the so-called “mandatory budget funds” to pay for the proposed $825 million increase, as well as $1 billion of the NIH’s existing budget is a good idea?

More »